LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2016

Jul 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2016-07-21

Reporting Person: Hemmeter Molly (Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-21	Incentive Stock Option (Right to Buy)	$11.35	M	150000	Acquired	2023-07-21	Common Stock (150000)	Direct
2016-07-21	Right to Buy Restricted Stock Unit (RSU)	$	M	50000	Acquired		Common Stock (50000)	Direct

Footnotes

F1: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock.

F2: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F3: 1/36 of the grant becomes exercisable on each monthly anniversary of the grant date.